XPH

State Street SPDR S&P Pharmaceuticals ETF

$67.93

0.83%
CategoryHealthcare

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

Source: Yahoo Finance
Q-Score14/ 100
Net Assets$463M
P/E—
Dividend Yield0.42%
52-Week Range—
Expense Ratio0.35%
1Y Return+38.6%
Beta0.79
AI summary

Price & performance

1M+5.1%
3M-3.0%
YTD+23.4%
1Y+38.6%
52-week range—
Beta0.79
Full chart and returns against a benchmark

Q-Score

14/ 100

Quality against peers; 50 is the peer median.

Growth33
Risk35
Performance46
Valuation18
Profitability7
Leverage35
Sentiment52
Every score and metric

News sentiment

Open News & Signals

Top holdings

Every holding and the look-through

Fund facts

Expense ratio0.35%
Net assets$463M
1-year return+38.6%
Top-10 coverage32.1%
Dividend yield0.42%
Concentration and breadth